Mortality and Sudden death risk in middle-aged persons with epilepsy -- a UK Biobank study

Ravi A. Shah,C. Anwar A. Chahal,Shaheryar Ranjha,Ghaith Sharaf Dabbagh,Babken Asatryan,Ivan Limongelli,Mohammed Khanji,Fabrizio Ricci,Federica De Paoli,Susanna Zucca,Martin Tristani-Firouzi,Erik K. St. Louis,Elson L. So,Virend K. Somers,Shah,R. A.,Chahal,C. A. A.,Ranjha,S.,Sharaf Dabbagh,G.,Asatryan,B.,Limongelli,I.,Khanji,M.,Ricci,F.,De Paoli,F.,Zucca,S.,Tristani-Firouzi,M.,St Louis,E. K.,So,E. L.,Somers,V. K.

DOI: https://doi.org/10.1101/2023.07.26.23293226

2023-07-29

MedRxiv

Abstract:Background. Sudden death is the leading cause of mortality in medically refractory cases of epilepsy. Younger persons with epilepsy (PWE), particularly those <40 years, have higher all-cause mortality than those without. However, data are conflicting about mortality and burden of cardiovascular disease (CVD) in middle-aged PWE. Objective: Determine all-cause and sudden death-specific mortality and burden of CVD in PWE in a middle-aged population. Methods. Using UK Biobank, we identified 7,786 (1.6%) participants with a diagnosis of epilepsy; 566 individuals with prior history of stroke were excluded. The 7,220 PWE comprised the study cohort with the remaining 494,676 without epilepsy as the comparator group. PWE were identified based on clinical diagnostic code (validated) or self-reported diagnosis at assessment centre interview. Prevalence of CVD was determined using validated diagnostic codes. Cox proportional hazards regression were used to assess all-cause mortality and sudden death risk, in PWE vs those without epilepsy. Results. Hypertension, coronary artery disease, heart failure, valvular heart disease, and congenital heart disease were all more prevalent in PWE. Arrhythmias including atrial fibrillation/flutter (12.2% vs 6.9%; p<0.01), bradyarrhythmias (7.7% vs 3.5%; p<0.01), conduction defects (6.1% vs 2.6%; p<0.01), and ventricular arrhythmias (2.3% vs 1.0%; p<0.01), as well as cardiac implantable electric devices (4.6% vs 2.0%; p<0.01) were all more common in PWE compared to comparator group. PWE had higher all-cause mortality (HR 3.9 [95% CI, 3.01-3.39]), higher sudden death-specific mortality (HR 6.65 [95% CI, 4.53-9.77]) both adjusted for age, sex and comorbidities; and were almost 2 years younger at death [68.1 vs 69.8; p<0.001]. Conclusions. PWE have markedly higher burden of CVD including arrhythmias and heart failure. Middle-aged PWE have increased all-cause and sudden death specific mortality and higher burden of CVD. While efforts have focused on SUDEP in the young, further work is required to elucidate mechanisms underlying all-cause mortality and sudden death risk in PWE of middle age, to identify prognostic biomarkers and develop preventative therapies in PWE.